131 related articles for article (PubMed ID: 35099177)
1. In Vitro and In Silico Analysis of the Residence Time of Serotonin 5-HT
Penna E; Niso M; Podlewska S; Volpicelli F; Crispino M; Perrone-Capano C; Bojarski AJ; Lacivita E; Leopoldo M
ACS Chem Neurosci; 2022 Feb; 13(4):497-509. PubMed ID: 35099177
[TBL] [Abstract][Full Text] [Related]
2. Pharmacophore Comparison and Development of Recently Discovered Long Chain Arylpiperazine and Sulfonamide Based 5-HT7 Ligands.
Rague A; Tidgewell K
Mini Rev Med Chem; 2018; 18(7):552-560. PubMed ID: 28901854
[TBL] [Abstract][Full Text] [Related]
3. Structure-Activity Relationships and Therapeutic Potentials of 5-HT
Modica MN; Lacivita E; Intagliata S; Salerno L; Romeo G; Pittalà V; Leopoldo M
J Med Chem; 2018 Oct; 61(19):8475-8503. PubMed ID: 29767995
[TBL] [Abstract][Full Text] [Related]
4. Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.
Spadoni G; Bedini A; Bartolucci S; Pala D; Mor M; Riccioni T; Borsini F; Cabri W; Celona D; Marzi M; Tarzia G; Rivara S; Minetti P
Eur J Med Chem; 2014 Jun; 80():8-35. PubMed ID: 24763360
[TBL] [Abstract][Full Text] [Related]
5. 5-HT7 receptor modulators: Amino groups attached to biphenyl scaffold determine functional activity.
Kim Y; Park H; Lee J; Tae J; Kim HJ; Min SJ; Rhim H; Choo H
Eur J Med Chem; 2016 Nov; 123():180-190. PubMed ID: 27475109
[TBL] [Abstract][Full Text] [Related]
6. Structural insights into serotonin receptor ligands polypharmacology.
Podlewska S; Kafel R; Lacivita E; Satała G; Kooistra AJ; Vass M; de Graaf C; Leopoldo M; Bojarski AJ; Mordalski S
Eur J Med Chem; 2018 May; 151():797-814. PubMed ID: 29679900
[TBL] [Abstract][Full Text] [Related]
7. Design and synthesis of new homo and hetero bis-piperazinyl-1-propanone derivatives as 5-HT7R selective ligands over 5-HT1AR.
Intagliata S; Modica MN; Pittalà V; Salerno L; Siracusa MA; Cagnotto A; Salmona M; Romeo G
Bioorg Med Chem Lett; 2016 Aug; 26(16):4052-6. PubMed ID: 27396505
[TBL] [Abstract][Full Text] [Related]
8. Computer-aided insights into receptor-ligand interaction for novel 5-arylhydantoin derivatives as serotonin 5-HT
Kucwaj-Brysz K; Kurczab R; Jastrzębska-Więsek M; Żesławska E; Satała G; Nitek W; Partyka A; Siwek A; Jankowska A; Wesołowska A; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2018 Mar; 147():102-114. PubMed ID: 29425815
[TBL] [Abstract][Full Text] [Related]
9. Serotonin 5-HT7 receptor increases the density of dendritic spines and facilitates synaptogenesis in forebrain neurons.
Speranza L; Labus J; Volpicelli F; Guseva D; Lacivita E; Leopoldo M; Bellenchi GC; di Porzio U; Bijata M; Perrone-Capano C; Ponimaskin E
J Neurochem; 2017 Jun; 141(5):647-661. PubMed ID: 28122114
[TBL] [Abstract][Full Text] [Related]
10. Discovery of G Protein-Biased Ligands against 5-HT
Lee J; Kwag R; Lee S; Kim D; Woo J; Cho Y; Kim HJ; Kim J; Jeon B; Choo H
J Med Chem; 2021 Jun; 64(11):7453-7467. PubMed ID: 34032427
[TBL] [Abstract][Full Text] [Related]
11. Aminotriazines with indole motif as novel, 5-HT
Kułaga D; Jaśkowska J; Satała G; Latacz G; Śliwa P
Bioorg Chem; 2020 Nov; 104():104254. PubMed ID: 32919133
[TBL] [Abstract][Full Text] [Related]
12. Benzimidazolone-based serotonin 5-HT1A or 5-HT7R ligands: synthesis and biological evaluation.
Badarau E; Suzenet F; Bojarski AJ; Fînaru AL; Guillaumet G
Bioorg Med Chem Lett; 2009 Mar; 19(6):1600-3. PubMed ID: 19237285
[TBL] [Abstract][Full Text] [Related]
13. Structural modifications of the serotonin 5-HT7 receptor agonist N-(4-cyanophenylmethyl)-4-(2-biphenyl)-1-piperazinehexanamide (LP-211) to improve in vitro microsomal stability: A case study.
Lacivita E; Podlewska S; Speranza L; Niso M; Satała G; Perrone R; Perrone-Capano C; Bojarski AJ; Leopoldo M
Eur J Med Chem; 2016 Sep; 120():363-79. PubMed ID: 27318552
[TBL] [Abstract][Full Text] [Related]
14. Discovery of β-Arrestin Biased Ligands of 5-HT
Kim Y; Kim H; Lee J; Lee JK; Min SJ; Seong J; Rhim H; Tae J; Lee HJ; Choo H
J Med Chem; 2018 Aug; 61(16):7218-7233. PubMed ID: 30028132
[TBL] [Abstract][Full Text] [Related]
15. Radiosynthesis and in vivo evaluation of novel radioligands for PET imaging of cerebral 5-HT7 receptors.
Hansen HD; Herth MM; Ettrup A; Andersen VL; Lehel S; Dyssegaard A; Kristensen JL; Knudsen GM
J Nucl Med; 2014 Apr; 55(4):640-6. PubMed ID: 24566002
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel 5-substituted-2-aminotetralin analogs: 5-HT
Perry CK; Casey AB; Felsing DE; Vemula R; Zaka M; Herrington NB; Cui M; Kellogg GE; Canal CE; Booth RG
Bioorg Med Chem; 2020 Feb; 28(3):115262. PubMed ID: 31882369
[TBL] [Abstract][Full Text] [Related]
17. The microRNA-29a Modulates Serotonin 5-HT7 Receptor Expression and Its Effects on Hippocampal Neuronal Morphology.
Volpicelli F; Speranza L; Pulcrano S; De Gregorio R; Crispino M; De Sanctis C; Leopoldo M; Lacivita E; di Porzio U; Bellenchi GC; Perrone-Capano C
Mol Neurobiol; 2019 Dec; 56(12):8617-8627. PubMed ID: 31292861
[TBL] [Abstract][Full Text] [Related]
18. Receptor-based pharmacophores for serotonin 5-HT7R antagonists-implications to selectivity.
Kołaczkowski M; Nowak M; Pawłowski M; Bojarski AJ
J Med Chem; 2006 Nov; 49(23):6732-41. PubMed ID: 17154504
[TBL] [Abstract][Full Text] [Related]
19. Towards metabolically stable 5-HT7 receptor ligands: a study on 1-arylpiperazine derivatives and related isosters.
Lacivita E; De Giorgio P; Patarnello D; Niso M; Colabufo NA; Berardi F; Perrone R; Satala G; Duszynska B; Bojarski AJ; Leopoldo M
Exp Brain Res; 2013 Oct; 230(4):569-82. PubMed ID: 23571499
[TBL] [Abstract][Full Text] [Related]
20. Rational design in search for 5-phenylhydantoin selective 5-HT7R antagonists. Molecular modeling, synthesis and biological evaluation.
Kucwaj-Brysz K; Warszycki D; Podlewska S; Witek J; Witek K; González Izquierdo A; Satała G; Loza MI; Lubelska A; Latacz G; Bojarski AJ; Castro M; Kieć-Kononowicz K; Handzlik J
Eur J Med Chem; 2016 Apr; 112():258-269. PubMed ID: 26900658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
